0
0
Gandhinagar, January 29 — In a landmark achievement for India’s public healthcare system, the Institute of Kidney Diseases and Research Centre (IKDRC) in Gujarat has emerged as the country’s leading government hospital for kidney transplantation, performing a record 502 successful kidney transplants in 2025. The Ahmedabad-based institute’s milestone underscores how sustained public investment, advanced medical technology, and skilled clinical teams can significantly expand access to complex, life-saving care.
The achievement, confirmed by IKDRC officials this week, places the state-run hospital among the highest-volume kidney transplant centres in the country. Alongside kidney transplants, the institute also conducted 86 liver transplants in the same year, further strengthening its reputation as a comprehensive transplant hub.
A record year for public-sector transplantation
According to data shared by the institute, the 502 kidney transplants performed in 2025 included a diverse mix of procedures: 157 deceased-donor (cadaver) transplants, 90 swap transplants, 49 paediatric transplants, and 43 robotic-assisted kidney transplants. Notably, 170 patients came from states outside Gujarat, reflecting IKDRC’s growing national reach.
Dr. Pranjal Modi, Director of IKDRC and Vice-Chancellor of Gujarat University of Transplantation Sciences, told news agency IANS that the institute’s growth has been driven by both clinical expertise and policy support.
“This year alone, we conducted 502 kidney and 86 liver transplants. A large proportion of these procedures were carried out under the Ayushman Bharat–Pradhan Mantri Jan Aarogya Yojana (AB-PMJAY), ensuring that cost does not become a barrier to life-saving treatment,” Dr. Modi said.
In 2025, 318 kidney transplants at IKDRC were funded through the Ayushman Bharat scheme, India’s flagship public health insurance programme that covers secondary and tertiary care for economically vulnerable populations.
Why kidney transplantation matters
Chronic kidney disease (CKD) is a growing public health challenge in India. Estimates published in The Lancet Global Health suggest that nearly 115 million adults in India may be living with some form of CKD, with diabetes and hypertension as leading causes. For patients with end-stage kidney disease, dialysis offers temporary support, but kidney transplantation remains the most effective long-term treatment, improving survival and quality of life.
“Transplantation is not just about extending life; it’s about restoring productivity and dignity,” said Dr. S. Sanjay, a senior nephrologist at a government medical college in North India who was not associated with IKDRC. “What IKDRC has demonstrated is that high-quality transplant care is possible at scale within the public sector.”
Technology as a force multiplier
A key feature of IKDRC’s recent success has been its adoption of advanced surgical technologies. The institute introduced robotic-assisted kidney transplantation last year, a technique that allows surgeons to perform operations with enhanced precision through minimally invasive methods.
According to Dr. Modi, robotic transplants are expected to grow rapidly. “We performed 43 robotic kidney transplants last year. Our target is to cross 100 this year. Importantly, these procedures are provided free of cost, with expenses borne by the state government,” he said.
Robotic-assisted surgery is associated with smaller incisions, reduced blood loss, and faster recovery, though it requires significant infrastructure and training. Experts caution that while robotic surgery can improve outcomes in selected patients, it is not universally superior and must be evaluated alongside cost-effectiveness.
Expanding access through public funding
One of the most significant aspects of IKDRC’s achievement is its focus on affordability. By integrating transplant services with AB-PMJAY and state funding, the institute has enabled patients from economically weaker sections to access procedures that often cost several lakhs of rupees in private hospitals.
Health policy specialists say this model could be transformative if replicated elsewhere. “India has the surgical talent, but affordability has always been the bottleneck,” said Dr. Meena Khandelwal, a public health expert based in Delhi. “High-volume centres like IKDRC show how government hospitals can bridge that gap when financing and systems are aligned.”
Cadaver and swap transplants: addressing organ shortages
India continues to face a severe shortage of donor organs. According to the National Organ and Tissue Transplant Organization (NOTTO), the country’s organ donation rate remains below one donor per million population, far lower than in many high-income countries.
IKDRC’s performance in 157 cadaver transplants and 90 swap transplants is therefore particularly noteworthy. Swap transplants—where two or more donor-recipient pairs exchange organs due to blood group or compatibility issues—have been increasingly recognized as a way to expand transplant opportunities ethically and legally.
“Every successful swap or deceased-donor transplant represents not just a medical success but also a societal one,” said Dr. Sanjay. “It reflects public trust in the system.”
Limitations and challenges ahead
Despite the impressive numbers, experts emphasize that challenges remain. Long-term post-transplant care, including lifelong immunosuppression and monitoring, is resource-intensive. Ensuring consistent follow-up for patients from distant states can be difficult.
There are also broader systemic issues. While high-volume centres excel, access to transplantation remains uneven across India, with rural and underserved regions still lacking referral pathways and awareness.
Moreover, experts caution against viewing transplant numbers alone as the sole indicator of success. “Outcomes such as graft survival, patient survival, and quality of life over five to ten years are equally important,” Dr. Khandelwal noted.
What this means for patients and families
For individuals living with advanced kidney disease, IKDRC’s achievement offers a measure of hope. It demonstrates that advanced, evidence-based care is increasingly available within the public healthcare system, reducing dependence on expensive private facilities.
For families, it also reinforces the importance of organ donation awareness. Increased deceased donation can dramatically shorten waiting times and save thousands of lives each year.
Setting an example nationally
As India grapples with rising rates of non-communicable diseases, the demand for organ transplantation is expected to grow. IKDRC’s record year provides a compelling case study in how public hospitals can combine technology, skilled manpower, and government support to deliver world-class care at scale.
While replication will require sustained investment and strong governance, health experts agree that the Gujarat model offers valuable lessons for the rest of the country.
Medical Disclaimer
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
